Clin2
NCT07639073Possibly a fitNot yet recruiting

Low-dose isotretinoin for moderate to severe acne

Acne Vulgaris

Treatments studied

Part of Skin clinical trials.

This study compares two doses of an acne pill called isotretinoin to see if a lower dose works as well as the standard dose with fewer side effects. If you have moderate to severe acne, this trial might help you find an effective treatment with less risk of side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
164 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You have moderate to severe acne (not mild acne).
  • You are not pregnant or breastfeeding.
  • You do not have hormonal disorders like PCOS, and your acne is not caused by medication.
  • You are not currently taking any acne treatment or corticosteroids, and you do not have serious health issues like high cholesterol, or kidney or liver failure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07539129Not yet recruiting
Probiotics for moderate acne

This study tests whether taking an oral probiotic (a 'good bacteria' supplement) can improve moderate acne and reduce inflammation in the body, compared to a placebo (a pill with no active ingredient). If you have moderate acne, this could be a gentler way to treat it without using stronger medications.

Rawalpindi, Punjab Province
NCT06225570Recruiting· Early Phase 1
Weekly isotretinoin vs tetracycline for moderate acne

This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.

Charleston, South Carolina
NCT06447480Recruiting· Phase 3
Comparing isotretinoin to standard care for moderate acne in darker skin

This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.

Nice, Alpes-Maritimes
NCT07818525Recruiting
Hormone levels and response to isotretinoin for acne in women

This study looks at how a woman's natural hormone levels affect how well she responds to isotretinoin (a strong acne pill). It aims to help doctors predict which patients will benefit most from this treatment.

Küçükçekmece, Istanbul
NCT07834138Recruiting
Study of facial skin bacteria in acne patients treated with isotretinoin

This study looks at how the bacteria on your face change when you take a medicine called isotretinoin for acne. It might help doctors understand why the medicine works and how to improve acne treatment.

Can Tho
NCT06725290Not yet recruiting
Dry eye in people taking isotretinoin for acne

This study looks at whether a common acne medication called isotretinoin can cause dry eye. It is for people with moderate to severe acne who are already taking this medication.

Hear when a new Acne Vulgaris trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.